Last Updated: May 26, 2026

CLINICAL TRIALS PROFILE FOR DYSPORT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DYSPORT

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00134810 ↗	Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome	Completed	Ipsen	Phase 2	2005-03-01	The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.
NCT00149240 ↗	Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome	Completed	Ipsen	Phase 2	2005-01-01	The main purpose of this study is to determine the effectiveness and safety of one dose of botulinum toxin type A (Dysport) associated with rehabilitation treatment on pain control in patients with a type of back pain called primary myofascial pain syndrome.
NCT00210444 ↗	Efficacy Study of Dysport® in the Treatment of Anal Fissure.	Completed	Ipsen	Phase 2	2003-06-01	To evaluate the effect on healing rates of two different prognostic factors in patients treated with Dysport® for anal fissure: duration of fissure and dose of study drug
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DYSPORT

Condition Name

Chart
Table

Condition Name for DYSPORT
Intervention	Trials
Cervical Dystonia	9
Cerebral Palsy	6
Overactive Bladder	6
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DYSPORT
Intervention	Trials
Muscle Spasticity	13
Dystonia	11
Dystonic Disorders	10
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DYSPORT

Trials by Country

Map
Table

Trials by Country for DYSPORT
Location	Trials
United States	214
France	14
Poland	14
Czech Republic	12
Germany	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DYSPORT
Location	Trials
Florida	17
California	17
New York	15
Texas	14
Pennsylvania	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DYSPORT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DYSPORT
Clinical Trial Phase	Trials
PHASE4	2
PHASE3	1
Phase 4	27
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DYSPORT
Clinical Trial Phase	Trials
Completed	62
Terminated	11
Recruiting	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DYSPORT

Sponsor Name

Chart
Table

Sponsor Name for DYSPORT
Sponsor	Trials
Ipsen	44
Galderma R&D	4
Medicis Pharmaceutical Corporation	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DYSPORT
Sponsor	Trials
Industry	60
Other	57
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.